October 21st 2024
A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Laparoscopy better than imaging for accurate staging in locally advanced cervical cancer
January 11th 2021While no difference was shown in disease-free survival rates between surgical and non-surgical staging methods, laparoscopy benefits patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIB cervical cancer. Surgical staging also has a cancer-specific survival benefit, according to a study published in the International Journal of Gynecological Cancers.
Read More
Improved survival rate in patients with advanced endometrial cancer
December 31st 2020Pembrolizumab plus lenvatinib induced a statistically significant and clinically meaningful improvement in overall survival, progression-free survival, and objective response rate compared with chemotherapy in patients with advanced endometrial cancer after prior systemic therapy in the phase 3 KEYNOTE-775/Study 309 trial.
Read More
Sexual health after cancer treatment
December 4th 2020The vast majority of cancer survivors reported that they experience sexual side effects after chemotherapy, radiation and other cancer treatments according to the results of a survey presented at the annual meeting of the American Society for Radiation Oncology.
Read More
Novel engineered cytokine plus pembrolizumab to treat ovarian cancer
November 24th 2020Heavily pretreated ovarian cancer patients who received a combination therapy of a novel engineered interleukin-2 (IL-2) cytokine plus pembrolizumab achieved an acceptable safety profile, according to a small cohort of an ongoing phase 1/2 trial.
Read More
Recurrence of high-grade cervical dysplasia
September 18th 2020Women with high-grade cervical dysplasia are much less likely to have recurrence after primary conization if they undergo laser conization than a loop electrosurgical excision procedure (LEEP), according to a 5-year follow-up study.
Read More
Does dual antibiotic prevention and vaginal prep decrease surgical site infections?
August 12th 2020Based on the literature, a bundled intervention was created that included dual antibiotic prophylaxis (cefazolin and metronidazole) aimed at reducing surgical site infections for all patients undergoing hysterectomy.
Read More
Does minimally invasive surgery for cervical cancer = longer survival?
November 20th 2018While minimally invasive and open surgeries have been found to produce similar survival rates in other early cancers, that might not be the case for early cervical cancer. PLUS: At what age should cervical cancer screening stop? ALSO: How much do genetic variants affect breast cancer risk?
Read More